Protective effect of moderate hypothermia on severe traumatic brain injury in children

Hao Li1, Guoping Lu, Wei Shi

  • 1Department of Pediatric Surgery, Children's Hospital of Fudan University, Shanghai, China.

Insights

Moderate hypothermia safely reduced intracranial pressure and protected neurons in children with severe traumatic brain injury (TBI). This neuroprotective effect was observed by lower biomarker levels and reduced mortality in the hypothermia group.

Area of Science:

  • Pediatric Neurology
  • Neurocritical Care
  • Trauma Surgery

Background:

  • Severe traumatic brain injury (TBI) in children presents significant management challenges.
  • Elevated intracranial pressure (ICP) and neuronal damage are critical concerns following pediatric TBI.
  • Neuroprotective strategies are essential to improve outcomes in severe pediatric TBI.

Purpose of the Study:

  • To evaluate the safety and neuroprotective efficacy of moderate hypothermia in children with severe TBI.
  • To compare the effects of moderate hypothermia versus normothermia on ICP and specific biomarkers.
  • To assess the impact of hypothermia on mortality and physiological parameters.

Main Methods:

  • A randomized controlled trial involving 22 children with severe TBI.
  • Treatment groups: moderate hypothermia (34.5°C for 72h) and normothermia (38.0°C).
  • Measured ICP, cerebrospinal fluid levels of NSE, S-100, CK-BB, pH, electrolytes, and heart rate.

Main Results:

  • Moderate hypothermia significantly reduced ICP compared to normothermia at all time points (p < 0.01).
  • Biomarkers of neuronal injury (NSE, S-100, CK-BB) were significantly lower in the hypothermia group (p < 0.01).
  • The hypothermia group showed a trend towards lower mortality (8.3% vs. 20%) and maintained normal pH and electrolyte balance.

Conclusions:

  • Moderate hypothermia is a safe and effective neuroprotective strategy for severe pediatric TBI.
  • Maintaining intracranial temperature at 34.5°C for 72 hours reduces ICP and neuronal damage.
  • Hypothermia therapy demonstrates potential to improve outcomes and reduce mortality in this patient population.